Prosecution over drug price fixing collapsesBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a814 (Published 14 July 2008) Cite this as: BMJ 2008;337:a814
- Clare Dyer
Five drug companies and nine directors accused of a multimillion pound conspiracy to swindle the NHS by fixing the prices of generic drugs are poised to escape criminal charges after a judge threw out the case against them, subject to appeal.
The eight year prosecution, which has cost taxpayers around £25m (€31m; $50m), looks set to collapse after the ruling by Mr Justice Pitchford at Southwark Crown Court last week. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial